Orrel Weizman
Orrel Weizman
Verified email at
Cited by
Cited by
Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2
AL Wyllie, J Fournier, A Casanovas-Massana, M Campbell, M Tokuyama, ...
New England Journal of Medicine 383 (13), 1283-1286, 2020
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets
CBF Vogels, AF Brito, AL Wyllie, JR Fauver, IM Ott, CC Kalinich, ...
Nature microbiology 5 (10), 1299-1305, 2020
Neuroinvasion of SARS-CoV-2 in human and mouse brain
E Song, C Zhang, B Israelow, A Lu-Culligan, AV Prado, S Skriabine, P Lu, ...
Journal of Experimental Medicine 218 (3), 2021
Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs
AL Wyllie, J Fournier, A Casanovas-Massana, M Campbell, M Tokuyama, ...
MedRxiv, 2020
ILC1 confer early host protection at initial sites of viral infection
OE Weizman, NM Adams, IS Schuster, C Krishna, Y Pritykin, C Lau, ...
Cell 171 (4), 795-808. e12, 2017
Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance
TE O’Sullivan, M Rapp, X Fan, OE Weizman, P Bhardwaj, NM Adams, ...
Immunity 45 (2), 428-441, 2016
Epigenetic control of innate and adaptive immune memory
CM Lau, NM Adams, CD Geary, OE Weizman, M Rapp, Y Pritykin, ...
Nature immunology 19 (9), 963-972, 2018
Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal–Hreidarsson syndrome
Z Deng, G Glousker, A Molczan, AJ Fox, N Lamm, J Dheekollu, ...
Proceedings of the National Academy of Sciences 110 (36), E3408-E3416, 2013
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
T Zhou, W Damsky, OE Weizman, MK McGeary, KP Hartmann, CE Rosen, ...
Nature 583 (7817), 609-614, 2020
Transcription factor IRF8 orchestrates the adaptive natural killer cell response
NM Adams, CM Lau, X Fan, M Rapp, CD Geary, OE Weizman, ...
Immunity 48 (6), 1172-1182. e6, 2018
Atg5 is essential for the development and survival of innate lymphocytes
TE O’Sullivan, CD Geary, OE Weizman, TL Geiger, M Rapp, GW Dorn II, ...
Cell reports 15 (9), 1910-1919, 2016
Core-binding factor β and Runx transcription factors promote adaptive natural killer cell responses
M Rapp, CM Lau, NM Adams, OE Weizman, TE O’Sullivan, CD Geary, ...
Science immunology 2 (18), eaan3796, 2017
Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12
OE Weizman, E Song, NM Adams, AD Hildreth, L Riggan, C Krishna, ...
Nature immunology 20 (8), 1004-1011, 2019
Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model
E Song, C Zhang, B Israelow, A Lu-Culligan, A Sprado, S Skriabine, P Lu, ...
Cytomegalovirus infection drives avidity selection of natural killer cells
NM Adams, CD Geary, EK Santosa, D Lumaquin, JB Le Luduec, R Sottile, ...
Immunity 50 (6), 1381-1390. e5, 2019
Epitope-specific vaccination limits clonal expansion of heterologous naive T cells during viral challenge
LR Johnson, OE Weizman, M Rapp, SS Way, JC Sun
Cell reports 17 (3), 636-644, 2016
IL-18 immunotherapy is efficacious against checkpoint-immunotherapy refractory tumors by promoting the maturation of highly proliferative, polyfunctional NK cells
OE Weizman, T Zhou, W Damsky, M McGeary, MW Bosenberg, AM Ring
Cancer Research 80 (16_Supplement), 3424-3424, 2020
IL-18 pathway agonism expands intratumoral PD1+ Tcf1+ stem-like CD8+ cells and their polyfunctional effector progeny to promote anti-tumor immunity
T Zhou, OE Weizman, W Damsky, M McGeary, MW Bosenberg, AM Ring
Cancer Research 80 (16_Supplement), 2156-2156, 2020
Conventional type 2 dendritic cells and natural killer cells mediate control of early metastatic seeding
OE Weizman, I Krykbaeva, M Bosenburg, A Iwasaki
The Journal of Immunology 204 (1 Supplement), 88.17-88.17, 2020
Чувствительность теста на определение вируса SARS-CoV-2 у пациентов с COVID-19 в образцах слюны выше чем в мазках носоглотки.
AL Wyllie, J Fournier, A Casanovas-Massana, M Campbell, M Tokuyama, ...
The system can't perform the operation now. Try again later.
Articles 1–20